- Home
- WENN vs AVTX Comparison
WENN vs AVTX Comparison
Compare WENN & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$16.85
Company Overview
Basic Information| Metric | WENN | AVTX |
|---|---|---|
| Founded | 2025 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 381.2M | 339.9M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | WENN | AVTX |
|---|---|---|
| Price | $10.18 | $16.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $32.57 |
| AVG Volume (30 Days) | 160.4K | ★ 547.6K |
| Earning Date | 01-01-0001 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.66 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,813,137.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $9.67 | $3.39 |
| 52 Week High | $10.38 | $20.72 |
Technical Indicators
Market Signals| Indicator | WENN | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.34 | 52.46 |
| Support Level | $10.15 | $15.36 |
| Resistance Level | $10.21 | $19.26 |
| Average True Range (ATR) | 0.01 | 1.29 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 54.25 | 60.70 |
Price Performance
Historical Comparison WENN
AVTX
About WENN Wen Acquisition Corp Class A Ordinary Shares
Wen Acquisition Corp is a blank check company.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).